부산대학교 도서관

Rebordosa C; Aguado J; Bartsch J; Saigi-Morgui N; Carsin AE; Garcia-Esteban R; Ignatova E; Freedman D; Perez-Gutthann S; Rivero-Ferrer E

International Journal of COPD, Vol 21, Iss Issue 1, Pp 1-15 (2026)

Kaniecki RG; Taylor FR

Publisher: Wiley-Blackwell ISSN: 0017-8748

Castellsague, J; Perez-Gutthann, S; Calingaert, B; Bui, C; Varas-Lorenzo, C; Arana, A; Prados-Torres, A; Poblador-Plou, B; Gonzalez-Rubio, F; Giner-Soriano, M

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 26(6):615-624

de, Vogel S; Seeger, JD; Arana, A; Margulis, AV; McQuay, LJ; Perez-Gutthann, S; Hallas, J; Kristiansen, NS; Linder, M; Odsbu, I

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 33(5)

Climacteric. 3:212-213

Joan Fortuny; Gero von Gersdorff; Régis Lassalle; Marie Linder; Jetty Overbeek; Jonas Reinold; Gunnar Toft; Antje Timmer; Jochen Dress; Patrick Blin; Cécile Droz‐Perroteau; Vera Ehrenstein; Carla Franzoni; Ron Herings; Bianca Kollhorst; Nicholas Moore; Ingvild Odsbu; Susana Perez‐Gutthann; Tania Schink; Katherine Rascher; Lawrence Rasouliyan; Kenneth J. Rothman; Nuria Saigi‐Morgui; Mathias Schaller; Elisabeth Smits; Michael Forstner; Jacques Bénichou; Andreas J. Bircher; Edeltraut Garbe; David S. Rampton; Lia Gutierrez

Pharmacoepidemiol Drug Saf
Intravenous Iron Consortium 2021, 'Use of intravenous iron and risk of anaphylaxis : A multinational observational post-authorisation safety study in Europe', Pharmacoepidemiology and Drug Safety, vol. 30, no. 10, pp. 1447-1457. https://doi.org/10.1002/pds.5319
Toft, G, Ehrenstein, V, Rothman, K J & Intravenous Iron Consortium 2021, 'Use of intravenous iron and risk of anaphylaxis : A multinational observational post-authorisation safety study in Europe', Pharmacoepidemiology and Drug Safety, vol. 30, no. 10, pp. 1447-1457. https://doi.org/10.1002/pds.5319

Rebordosa C; Plana E; Rubino A; Aguado J; Martinez D; Lei A; Daoud S; Saigi-Morgui N; Perez-Gutthann S; Rivero-Ferrer E

International Journal of COPD, Vol 17, Pp 1715-1733 (2022)

Rebordosa C; Plana E; Rubino A; Aguado J; Lei A; Daoud S; Saigi-Morgui N; Perez-Gutthann S; Rivero-Ferrer E

International Journal of COPD, Vol 16, Pp 1461-1475 (2021)

Kurz X; European Specialised Expert Community, European Medicines Agency, Amsterdam, the Netherlands.; Cohet C; Real-World Evidence Workstream, Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, the Netherlands.; Perez-Gutthann S; Regulatory Grade RWE & Epidemiology, RTI Health Solutions, Barcelona, Spain.; Rao S; Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.; Gardarsdottir H; Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands.; Department of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland.; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, the Netherlands.

Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

Arana A; Pottegård A; Kuiper JG; Booth H; Reutfors J; Calingaert B; Lund LC; Crellin E; Schmitt-Egenolf M; Kaye JA; Gembert K; Rothman KJ; Kieler H; Dedman D; Houben E; Gutiérrez L; Hallas J; Perez-Gutthann S

Clinical Epidemiology, Vol 13, Pp 1141-1153 (2021)

Drug Week. January 12, 2018, p9874.

K. Berencsi; A. Sami; M.S. Ali; K. Marinier; N. Deltour; S. Perez-Gutthann; L. Pedersen; P. Rijnbeek; J. Van der Lei; F. Lapi; M. Simonetti; C. Reyes; M.C.J.M. Sturkenboom; D. Prieto-Alhambra

Berencsi, K, Sami, A, Ali, M S, Marinier, K, Deltour, N, Perez-Gutthann, S, Pedersen, L, Rijnbeek, P, Van der Lei, J, Lapi, F, Simonetti, M, Reyes, C, Sturkenboom, M C J M & Prieto-Alhambra, D 2020, 'Impact of risk minimisation measures on the use of strontium ranelate in Europe : a multi-national cohort study in 5 EU countries by the EU-ADR Alliance', Osteoporosis International, vol. 31, no. 4, pp. 721-755. https://doi.org/10.1007/s00198-019-05181-6

Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy.; Gutierrez L; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Swertz MA; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.; Hyde E; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.; Sturkenboom M; University Medical Centre Utrecht, Utrecht, The Netherlands.; Arana A; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Franzoni C; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.; Roberto G; Agenzia Regionale di Sanità della Toscana, Florence, Italy.; Gil M; Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.; Maciá MA; Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.; Schäfer W; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Haug U; Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Faculty of Human and Health Science, University of Bremen, Bremen, Germany.; Thurin NH; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Lassalle R; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Zaccagnino S; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Busto MP; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Middelkoop B; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Gembert K; Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden.; Sanchez-Saez F; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Rodriguez-Bernal C; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Sanfélix-Gimeno G; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Hurtado I; Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Acosta MB; Spanish Working Group on Crohn's Disease and Ulcerative Colitis, Bilbao, Spain.; Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Carmona-Pírez J; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain.; Gimeno-Miguel A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Schultze A; London School of Hygiene and Tropical Medicine, London, UK.; Jansen E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Herings R; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Locatelli I; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.; Jazbar J; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.; Žerovnik Š; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.; Kos M; Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.; Smit S; Institute of Genomics, University of Tartu, Tartu, Estonia.; Lind S; Institute of Genomics, University of Tartu, Tartu, Estonia.; Metspalu A; Institute of Genomics, University of Tartu, Tartu, Estonia.; Simou S; European Medicines Agency, Amsterdam, The Netherlands.; Hedenmalm K; European Medicines Agency, Amsterdam, The Netherlands.; Cochino A; European Medicines Agency, Amsterdam, The Netherlands.; Alcini P; European Medicines Agency, Amsterdam, The Netherlands.; Kurz X; European Medicines Agency, Amsterdam, The Netherlands.; Perez-Gutthann S; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.

Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

Gini R; Agenzia Regionale di Sanità Della Toscana, Florence, Italy.; Pajouheshnia R; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Gutierrez L; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Swertz MA; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.; Hyde E; Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.; Sturkenboom M; Department of Datascience and Biostatistics, University Medical Centre Utrecht, Utrecht, The Netherlands.; Arana A; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Franzoni C; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.; Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.; Roberto G; Agenzia Regionale di Sanità Della Toscana, Florence, Italy.; Gil M; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.; Maciá MA; Base de Datos Para la Investigación Farmacoepidemiológica en Atención Primaria, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.; Schäfer W; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Haug U; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.; Faculty of Human and Health Science, University of Bremen, Bremen, Germany.; Thurin NH; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Lassalle R; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux, Bordeaux, France.; Zaccagnino S; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Busto MP; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Middelkoop B; European Society for Blood & Marrow Transplantation, Leiden, The Netherlands.; Gembert K; Department of Epidemiology, Karolinska Institutet, Stockholm, Sweden.; Sanchez-Saez F; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Rodriguez-Bernal C; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Sanfélix-Gimeno G; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Hurtado I; Health Services Research & Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Valencia, Spain.; Acosta MB; Spanish Working Group on Crohn's Disease and Ulcerative Colitis, Bilbao, Spain.; Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Carmona-Pírez J; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Technical Advisory Subdirectorate of Information Management (STAGI), Andalusian Health Service (SAS), Seville, Spain.; Gimeno-Miguel A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Prados-Torres A; EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, Zaragoza, Spain.; Schultze A; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.; Jansen E; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Herings R; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Kuiper J; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Locatelli I; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.; Jazbar J; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.; Žerovnik Š; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.; Kos M; University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia.; Smit S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.; Lind S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.; Metspalu A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia.; Simou S; European Medicines Agency, Amsterdam, The Netherlands.; Hedenmalm K; European Medicines Agency, Amsterdam, The Netherlands.; Cochino A; European Medicines Agency, Amsterdam, The Netherlands.; Alcini P; European Medicines Agency, Amsterdam, The Netherlands.; Kurz X; European Medicines Agency, Amsterdam, The Netherlands.; Perez-Gutthann S; Department of Epidemiology, RTI Health Solutions, Barcelona, Spain.

Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

Berencsi, K.; Sami, A.; Ali, M. S.; Marinier, K.; Deltour, N.; Perez-Gutthann, S.; Pedersen, L.; Rijnbeek, P.; Van der Lei, J.; Lapi, F.; Simonetti, M.; Reyes, C.; Sturkenboom, M. C.J.M.; Prieto-Alhambra, D.

Berencsi, K, Sami, A, Ali, M S, Marinier, K, Deltour, N, Perez-Gutthann, S, Pedersen, L, Rijnbeek, P, Van der Lei, J, Lapi, F, Simonetti, M, Reyes, C, Sturkenboom, M C J M & Prieto-Alhambra, D 2020, 'Correction to : Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance (Osteoporosis International, (2020), 31, 4, (721-755), 10.1007/s00198-019-05181-6)', Osteoporosis International, vol. 31, no. 4, pp. 799. https://doi.org/10.1007/s00198-020-05314-2

Hallas, Jesper; Margulis, Andrea V.; Pottegård, Anton; Kristiansen, Nina S.; Atsma, Willem J.; Appenteng, Kwame; de Vogel, Stefan; Kaye, James A.; Perez-Gutthann, Susana; Arana, Alejandro

Hallas, J, Margulis, A V, Pottegård, A, Kristiansen, N S, Atsma, W J, Appenteng, K, de Vogel, S, Kaye, J A, Perez-Gutthann, S & Arana, A 2018, ' Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder : A Danish Nationwide Cohort Study ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 6, pp. 612-619 . https://doi.org/10.1111/bcpt.12965

Hoffman V; Optum, 1325 Boylston Street, Boston, MA, 02215, USA.; Hallas J; University of Southern Denmark, Odense, Denmark.; Linder M; Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.; Margulis AV; RTI Health Solutions, Barcelona, Spain.; Suehs BT; Humana Healthcare Research, Louisville, KY, USA.; Arana A; RTI Health Solutions, Barcelona, Spain.; Phiri K; Optum, 1325 Boylston Street, Boston, MA, 02215, USA.; Enger C; Optum, 1325 Boylston Street, Boston, MA, 02215, USA.; Horter L; Humana Healthcare Research, Louisville, KY, USA.; Odsbu I; Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.; Olesen M; University of Southern Denmark, Odense, Denmark.; Perez-Gutthann S; RTI Health Solutions, Barcelona, Spain.; Xu Y; Humana Healthcare Research, Louisville, KY, USA.; Kristiansen NS; University of Southern Denmark, Odense, Denmark.; Appenteng K; Astellas Pharma US, Chicago, IL, USA.; de Vogel S; Astellas Pharma Europe B.V., Leiden, The Netherlands.; Seeger JD; Optum, 1325 Boylston Street, Boston, MA, 02215, USA. John.Seeger@optum.com.

Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

Rebordosa C; RTI Health Solutions, Barcelona, Spain.; Thomsen RW; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.; Tave AK; Carelon Research, Wilmington, Delaware, USA.; Madsen M; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.; Beachler DC; Carelon Research, Wilmington, Delaware, USA.; Martinez D; RTI Health Solutions, Barcelona, Spain.; Garcia-Esteban R; RTI Health Solutions, Barcelona, Spain.; Plana E; RTI Health Solutions, Barcelona, Spain.; Tormos A; RTI Health Solutions, Barcelona, Spain.; Farsani SF; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; Perez-Gutthann S; RTI Health Solutions, Barcelona, Spain.; Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, Michigan, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

Willame, C; Dodd, C; Gini, R; Durán, CE; Thomsen, RM; Wang, L; Gedebjerg, A; Kahlert, J; Ehrenstein, V; Bartolini, C; Droz, C; Moore, N; Haug, U; Schink, T; Diez-Domingo, J; Mira-Iglesias, A; Vergara-Hernández, C; Carreras, JJ; Villalobos, F; Pallejà, M; Aragón, M; Perez-Gutthann, S; Arana, A; Giaquinto, C; Barbieri, E; Stona, L; Huerta, C; García Poza, P; de Burgos, A; Martínez-González, M; Souverein, P; Gardarsdottir, H; Siiskonen, SJ; Weibel, D; Mahy, P; Klungel, O; Sturkenboom, MCJM

Hoffman, Veena; Hallas, Jesper; Linder, Marie; Margulis, Andrea; Suehs, Brandon T; Arana, Alejandro; Enger, Cheryl; Horter, Libby; Odsbu, Ingvild; Olesen, Morten; Perez Gutthann, Susana; Xu, Yihua; Kristiansen, Nina S; Appenteng, Kwame; de Vogel, Stefan; Seeger, John D

Circulation. Nov 17, 2020 142(Suppl_3 Suppl 3):A13154-A13154